Catalyst Clinical Research welcomes Nik Morton as new CEO
Wilmington, NC, February 14, 2024 (PRNewswire) -- Catalyst Clinical Research appointed Nik Morton as its CEO. Stepping into the role from serving as the company's president and COO since 2022. Prior to joining Catalyst he held strategic positions at PPD bringing a wealth of experience and expertise to his new role.
Read full article here.
コメント